Irini Sereti
#118,575
Most Influential Person Now
Greek physician-scientist
Irini Sereti's AcademicInfluence.com Rankings
Irini Seretiphilosophy Degrees
Philosophy
#10899
World Rank
#14960
Historical Rank
Logic
#7921
World Rank
#9854
Historical Rank
Irini Seretibiology Degrees
Biology
#14907
World Rank
#18779
Historical Rank
Immunology
#1030
World Rank
#1056
Historical Rank
Download Badge
Philosophy Biology
Why Is Irini Sereti Influential?
(Suggest an Edit or Addition)According to Wikipedia, Irini Sereti is a Greek scientist and physician. She is chief of the HIV pathogenesis section at the National Institute of Allergy and Infectious Diseases. Sereti researches immune reconstitution inflammatory syndrome, idiopathic CD4 lymphocytopenia, and immune-based therapeutic strategies of HIV investigation.
Irini Sereti's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Plasma levels of soluble CD14 independently predict mortality in HIV infection. (2011) (983)
- The Common γ-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands (2008) (473)
- IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. (2009) (332)
- Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. (2011) (289)
- Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection (2012) (288)
- Identification of Dynamically Distinct Subpopulations of T Lymphocytes That Are Differentially Affected by HIV (2001) (244)
- Initiation of ART during Early Acute HIV Infection Preserves Mucosal Th17 Function and Reverses HIV-Related Immune Activation (2014) (223)
- Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study (2012) (203)
- Interleukin-7 promotes HIV persistence during antiretroviral therapy. (2013) (195)
- Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. (2008) (191)
- Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection (2010) (190)
- Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection (2017) (176)
- Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. (2010) (166)
- Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none (2012) (156)
- Risk Factor Analyses for Immune Reconstitution Inflammatory Syndrome in a Randomized Study of Early vs. Deferred ART during an Opportunistic Infection (2010) (144)
- Evidence for innate immune system activation in HIV type 1-infected elite controllers. (2014) (142)
- Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. (2003) (140)
- Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. (2005) (134)
- Cutting Edge: L-Selectin (CD62L) Expression Distinguishes Small Resting Memory CD4+ T Cells That Preferentially Respond to Recall Antigen (2003) (123)
- In vivo expansion of CD4+CD45RO–CD25+ T cells expressing foxP3 in IL-2-treated HIV-infected patients (2005) (118)
- Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs (2013) (117)
- Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS). (2016) (109)
- IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation. (2004) (102)
- Mycobacterial Antigen Driven Activation of CD14++CD16− Monocytes Is a Predictor of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome (2014) (102)
- Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome. (2012) (97)
- Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) in HIV Patients with Culture Confirmed Pulmonary Tuberculosis in India and the Potential Role of IL-6 in Prediction (2013) (96)
- Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis (2010) (88)
- Decreases in Colonic and Systemic Inflammation in Chronic HIV Infection after IL-7 Administration (2014) (85)
- Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV (2011) (85)
- CD4+ T Cells, Including Th17 and Cycling Subsets, Are Intact in the Gut Mucosa of HIV-1-Infected Long-Term Nonprogressors (2011) (85)
- Cycling of Gut Mucosal CD4+ T Cells Decreases after Prolonged Anti-Retroviral Therapy and is Associated with Plasma LPS Levels (2009) (84)
- Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort (2014) (83)
- Comprehensive analysis of unique cases with extraordinary control over HIV replication. (2012) (83)
- IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa. (2012) (79)
- Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy (2017) (77)
- Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. (2014) (77)
- IL‐15 acts as a potent inducer of CD4+CD25hi cells expressing FOXP3 (2008) (76)
- HIV infection and immune activation: the role of coinfections (2016) (74)
- Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm (2009) (73)
- HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases (2020) (73)
- Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells. (2002) (72)
- Treatment of progressive multifocal leukoencephalopathy with interleukin 7. (2014) (71)
- Naïve T-Cell Dynamics in Human Immunodeficiency Virus Type 1 Infection: Effects of Highly Active Antiretroviral Therapy Provide Insights into the Mechanisms of Naïve T-Cell Depletion (2006) (71)
- Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy (2016) (70)
- Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection (2002) (69)
- Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection (2016) (68)
- Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study. (2016) (67)
- Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. (2013) (66)
- Transmitted Raltegravir Resistance in An HIV-1 Crf_Ag-Infected Patient (2011) (65)
- In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. (2005) (61)
- Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice. (2010) (60)
- CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients (2001) (59)
- Vitamin D deficiency is associated with IL-6 levels and monocyte activation in HIV-infected persons (2017) (58)
- Metagenomic Discovery of 83 New Human Papillomavirus Types in Patients with Immunodeficiency (2018) (57)
- Evidence for translocation of microbial products in patients with idiopathic CD4 lymphocytopenia. (2009) (57)
- Alopecia universalis and Graves' disease in the setting of immune restoration after highly active antiretroviral therapy. (2001) (57)
- Interleukin‐2 induced immune effects in human immunodeficiency virus‐infected patients receiving intermittent interleukin‐2 immunotherapy (2001) (57)
- Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification (2015) (56)
- Administration of interleukin-7 increases CD4 T cells in idiopathic CD4 lymphocytopenia. (2016) (56)
- Serious Non-AIDS events: Immunopathogenesis and interventional strategies (2013) (56)
- Role of IL-6 in Mycobacterium avium–Associated Immune Reconstitution Inflammatory Syndrome (2014) (55)
- Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164. (2012) (54)
- Impact of early cART in the gut during acute HIV infection. (2016) (54)
- Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies. (2016) (52)
- Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection (2016) (50)
- Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome (2015) (49)
- Heme Oxygenase-1 Regulation of Matrix Metalloproteinase-1 Expression Underlies Distinct Disease Profiles in Tuberculosis (2015) (49)
- Idiopathic CD4 lymphocytopenia: a case of missing, wandering or ineffective T cells (2012) (49)
- Association of Arterial and Lymph Node Inflammation With Distinct Inflammatory Pathways in Human Immunodeficiency Virus Infection (2017) (48)
- Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearance. (2011) (47)
- Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes. (2011) (47)
- Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial. (2014) (47)
- Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses. (2013) (47)
- Detection of EBV genomes in plasmablasts/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH. (2010) (46)
- Lack of compartmentalization of HIV-1 quasispecies between the gut and peripheral blood compartments. (2011) (46)
- d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS. (2010) (45)
- Immune Reconstitution Disorders in Patients With HIV Infection: From Pathogenesis to Prevention and Treatment (2014) (45)
- A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRIS. (2016) (45)
- The Effect of Leflunomide on Cycling and Activation of T-Cells in HIV-1-Infected Participants (2010) (45)
- Immunometabolism and HIV-1 pathogenesis: food for thought (2020) (44)
- Can early therapy reduce inflammation? (2014) (42)
- Vitamin D, d-dimer, Interferon γ, and sCD14 Levels are Independently Associated with Immune Reconstitution Inflammatory Syndrome: A Prospective, International Study☆ (2016) (39)
- Interleukin 2 leads to dose-dependent expression of the alpha chain of the IL-2 receptor on CD25-negative T lymphocytes in the absence of exogenous antigenic stimulation. (2000) (38)
- Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy (2015) (38)
- Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation (2016) (36)
- Increased Metabolic Activity on 18F-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Human Immunodeficiency Virus–Associated Immune Reconstitution Inflammatory Syndrome (2018) (35)
- HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy (2011) (34)
- Immune activation and HIV: an enduring relationship. (2016) (34)
- Transmitted HIV Drug Resistance Is High and Longstanding in Metropolitan Washington, DC. (2016) (33)
- Immunopathogenesis of human immunodeficiency virus: implications for immune-based therapies. (2001) (31)
- Idiopathic CD 4 lymphocytopenia : natural history and prognostic factors (2008) (31)
- Decreased CD127 Expression on T Cells in HIV-1-infected Adults Receiving Antiretroviral Therapy With or Without Intermittent IL-2 Therapy (2006) (28)
- Prospective international study of incidence and predictors of immune reconstitution inflammatory syndrome and death in people with HIV and severe lymphopenia. (2020) (28)
- Quantifying and Predicting the Effect of Exogenous Interleukin-7 on CD4+T Cells in HIV-1 Infection (2014) (27)
- Emergence of Polyfunctional Cytotoxic CD4+ T Cells in Mycobacterium avium Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected Patients (2018) (25)
- Hallmarks of primate lentiviral immunodeficiency infection recapitulate loss of innate lymphoid cells (2018) (25)
- Preliminary evaluation of a highly automated instrument for the selection of CD34+ cells from mobilized peripheral blood stem cell concentrates (2016) (25)
- Decreased interleukin 7 responsiveness of T lymphocytes in patients with idiopathic CD4 lymphopenia. (2012) (24)
- Acute Retroviral Syndrome Is Associated With High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments (2018) (24)
- Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection. (2004) (23)
- Graves’ disease as immune reconstitution disease in HIV-positive patients is associated with naive and primary thymic emigrant CD4+ T-cell recovery (2014) (22)
- Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV (2012) (22)
- Prevalence of Strongyloides stercoralis in an urban US AIDS cohort (2012) (22)
- Differential expression of CXCR3 and CCR6 on CD4+ T-lymphocytes with distinct memory phenotypes characterizes tuberculosis-associated immune reconstitution inflammatory syndrome (2019) (21)
- CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients. (2008) (21)
- IL-7 treatment supports CD8+ mucosa-associated invariant T-cell restoration in HIV-1-infected patients on antiretroviral therapy. (2018) (20)
- Prospective study of a novel, radiation-free, reduced-intensity bone marrow transplantation platform for primary immunodeficiency diseases. (2020) (20)
- Severe Paradoxical Reaction During Treatment of Disseminated Tuberculosis in a Patient With Neutralizing Anti-IFNγ Autoantibodies. (2016) (20)
- Cerebrospinal fluid HIV-1 compartmentalization in a patient with AIDS and acute varicella-zoster virus meningomyeloradiculitis. (2013) (19)
- Evaluation of Canonical Inflammasome Activation in Human Monocytes by Imaging Flow Cytometry (2019) (19)
- Choroid Plexitis and Ependymitis by Magnetic Resonance Imaging are Biomarkers of Neuronal Damage and Inflammation in HIV-negative Cryptococcal Meningoencephalitis (2017) (18)
- CD4+ T cell responses to interleukin-2 administration in HIV-infected patients are directly related to the baseline level of immune activation. (2007) (18)
- Susceptibility to Cryptococcal Meningoencephalitis Associated With Idiopathic CD4+ Lymphopenia and Secondary Germline or Acquired Defects (2017) (17)
- Identification of rare HIV-1-infected patients with extreme CD4+ T cell decline despite ART-mediated viral suppression. (2019) (17)
- Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels (2009) (17)
- A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus. (2003) (16)
- Treatment of Relapsing HPV Diseases by Restored Function of Natural Killer Cells. (2021) (15)
- T-Cell Depletion in the Colonic Mucosa of Patients With Idiopathic CD4+ Lymphopenia. (2015) (15)
- Reconstitution of Peripheral T Cells by Tissue-Derived CCR4+ Central Memory Cells Following HIV-1 Antiretroviral Therapy (2016) (15)
- Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment (2022) (15)
- Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16− Monocytes From COVID-19 Patients (2022) (15)
- A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study. (2014) (15)
- Persistent oxidative stress and inflammasome activation in CD14highCD16- monocytes from COVID-19 patients (2021) (14)
- Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial (2009) (14)
- Impact of Acute HIV Infection and Early Antiretroviral Therapy on the Human Gut Microbiome. (2019) (13)
- Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS) (2019) (13)
- Investigation of patients treated by an HIV-infected cardiothoracic surgeon--Israel, 2007. (2009) (13)
- Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia. (2020) (13)
- Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients (2006) (13)
- IL-7 treatment supports CD8+ MAIT cell restoration in HIV-1 infected patients on ART. (2018) (12)
- Effects of Lymphocyte Isolation and Timing of Processing on Detection of CD127 Expression on T Cells in Human Immunodeficiency Virus-Infected Patients (2005) (12)
- Where have all the T cells gone? (2009) (12)
- Antiretroviral Therapy Administration in Healthy Rhesus Macaques Is Associated with Transient Shifts in Intestinal Bacterial Diversity and Modest Immunological Perturbations (2019) (11)
- Cytomegalovirus immune reconstitution inflammatory syndrome manifesting as acute appendicitis in an HIV-infected patient (2014) (11)
- The Effects of Recombinant Human Lactoferrin on Immune Activation and the Intestinal Microbiome Among Persons Living with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy. (2019) (11)
- Country of residence is associated with distinct inflammatory biomarker signatures in HIV-infected patients (2017) (11)
- The Effect of Intermittent IL-2 Therapy on CD4 T Cells in the Gut in HIV-1–Infected Patients (2011) (10)
- Immune Activation Is Associated with CD8 T Cell Interleukin-21 Production in HIV-1-Infected Individuals (2014) (10)
- Determinants of suboptimal CD4+ T cell recovery after antiretroviral therapy initiation in a prospective cohort of acute HIV‐1 infection (2020) (10)
- Factor Xa Inhibition Reduces Coagulation Activity but Not Inflammation Among People With HIV: A Randomized Clinical Trial (2020) (10)
- Disseminated nocardiosis in a patient with X-linked chronic granulomatous disease and human immunodeficiency virus infection. (2001) (9)
- Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy (2018) (9)
- An inflammatory composite score predicts mycobacterial IRIS in people with HIV and severe lymphopenia: A prospective international cohort study. (2020) (9)
- Cytomegalovirus retinitis successfully treated with ganciclovir implant in a patient with blood ganciclovir resistance and ocular ganciclovir sensitivity (2012) (9)
- Residual immune dysfunction under antiretroviral therapy. (2021) (9)
- Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living With Human Immunodeficiency Virus and Severe Lymphopenia (2020) (8)
- A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals (2017) (8)
- Multifocal tuberculosis-associated immune reconstitution inflammatory syndrome – a case report of a complicated scenario (2019) (8)
- Immune reconstruction inflammatory syndrome in HIV infection: beyond what meets the eye. (2020) (8)
- Clinical and immunologic predictors of Mycobacterium avium complex immune reconstitution inflammatory syndrome in a contemporary cohort of patients with HIV. (2020) (8)
- BAY 50-4798, a novel, high-affinity receptor-specific recombinant interleukin-2 analog, induces dose-dependent increases in CD25 expression and proliferation among unstimulated, human peripheral blood mononuclear cells in vitro. (2004) (8)
- The Hitchhiker Guide to CD4+ T-Cell Depletion in Lentiviral Infection. A Critical Review of the Dynamics of the CD4+ T Cells in SIV and HIV Infection (2021) (8)
- COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavir (2022) (8)
- Emergence of Kaposi’s Sarcoma Herpesvirus-Associated Complications Following Corticosteroid Use in TB-IRIS (2018) (8)
- Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients (2022) (8)
- HIV infection and the gut: scarred for life? (2008) (7)
- Residual Immune Activation and Latency. (2018) (7)
- Delayed sample processing leads to marked decreases in measured plasma IL-7 levels. (2006) (7)
- Lost in translation: Lack of CD4 expression due to a novel genetic defect. (2021) (6)
- Losartan to reduce inflammation and fibrosis endpoints in HIV disease (LIFE-HIV): results from a randomized placebo-controlled trial. (2020) (6)
- IRIS as a post-transplantation complication in primary immunodeficiency with disseminated M. avium. (2019) (6)
- Dynamics of T-Lymphocyte Activation Related to Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in Persons With Advanced HIV (2021) (6)
- Plasma Metabolomics Reveals Dysregulated Metabolic Signatures in HIV-Associated Immune Reconstitution Inflammatory Syndrome (2021) (6)
- Immune Reconstitution Inflammatory Syndrome as a Posttransplantation Complication in Primary Immunodeficiency With Disseminated Mycobacterium avium (2019) (6)
- ART in HIV-Positive Persons With Low Pretreatment Viremia: Results From the START Trial. (2019) (6)
- Hyperinflammatory syndromes after SARS-CoV-2 mRNA vaccination in individuals with underlying immune dysregulation. (2021) (5)
- An Inflammatory Composite Score Predicts Mycobacterial Immune Reconstitution Inflammatory Syndrome in People with Advanced HIV: A Prospective International Cohort Study (2020) (5)
- Serological Responses to Human Virome Define Clinical Outcomes of Italian Patients Infected with SARS-CoV-2 (2020) (5)
- Peptide library-based evaluation of T-cell receptor breadth detects defects in global and regulatory activation in human immunologic diseases (2013) (5)
- Naı¨ve T-Cell Dynamics in Human Immunodeficiency Virus Type 1 Infection: Effects of Highly Active Antiretroviral Therapy Provide Insights into the Mechanisms of Naı¨ve T-Cell Depletion (2006) (5)
- Plasma tissue factor and immune activation are associated with carotid intima-media thickness progression in treated HIV infection. (2020) (4)
- Biomarkers of Cellular Stress Do Not Associate with sCD14 in Progressive HIV and SIV Infections in Vivo (2020) (4)
- Humanized mouse models reveal an immunologic classification of idiopathic CD4 lymphocytopenia subtypes. (2019) (4)
- A Phase I, Randomized, Controlled Clinical Study of CC-11050 in People Living With HIV With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE). (2019) (4)
- Immune reconstitution inflammatory syndrome in HIV infection: taking the bad with the good. (2017) (4)
- Author Correction: Differential expression of CXCR3 and CCR6 on CD4+ T-lymphocytes with distinct memory phenotypes characterizes tuberculosis-associated immune reconstitution inflammatory syndrome (2019) (4)
- Clonal hematopoiesis is not significantly associated with COVID-19 disease severity (2022) (4)
- Classical complement and inflammasome activation converge in CD14highCD16- monocytes in HIV associated TB-immune reconstitution inflammatory syndrome (2021) (3)
- Characterization of autoantibodies, immunophenotype and autoimmune disease in a prospective cohort of patients with idiopathic CD4 lymphocytopenia. (2021) (3)
- Clinical Exome Sequencing of 1000 Families with Complex Immune Phenotypes: Towards comprehensive genomic evaluations. (2022) (3)
- Pomalidomide Induces Expansion of Activated and Central Memory CD4+ and CD8+ T Cells in Vivo in Patients with and without HIV Infection (2014) (3)
- Chronic Immune Activation in HIV (2014) (3)
- Hyperinflammatory Syndromes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA vaccination in Individuals With Underlying Immune Dysregulation (2021) (3)
- CHALLENGES IN MANAGEMENT OF WARFARIN ANTI-COAGULATION IN ADVANCED HIV/AIDS PATIENTS WITH VENOUS THROMBOTIC EVENTS--A CASE SERIES FROM A RESEARCH CLINIC IN RURAL KERICHO, KENYA. (2013) (3)
- The power of 1 in HIV therapeutics. (2011) (3)
- Idiopathic CD4 lymphopenia (2020) (3)
- Blockade of TGF-β signaling reactivates HIV-1/SIV reservoirs and immune responses in vivo (2022) (2)
- 373. Immune Reconstitution Inflammatory Syndrome in Patients with HIV/AIDS and Histoplasmosis: A Case Series (2019) (2)
- Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial (2017) (2)
- Severe mycobacterial IRIS in advanced HIV has features of hemophagocytic lymphohistiocytosis and requires prolonged immune suppression. (2022) (2)
- HIV and aging, biological mechanisms, and therapies: What do we know? (2022) (2)
- Factors associated with worse cerebrovascular function in aging women with and at risk for HIV. (2020) (2)
- Response to Bandera et al. (2015) (2)
- Preserved MAIT cell numbers and function in idiopathic CD4 lymphocytopenia. (2020) (2)
- To Induce Immune Reconstitution Inflammatory Syndrome or Suppress It: The Spectrum of Mycobacterium genavense in the Antiretroviral Era. (2021) (2)
- Elevated N‐terminal prohormone of brain natriuretic peptide among persons living with HIV in a South African peri‐urban township (2020) (2)
- Inflammatory Biomarkers Do Not Differ Between Persistently Seronegative vs Seropositive People With HIV After Treatment in Early Acute HIV Infection. (2020) (2)
- Neurotuberculosis: Control of Steroid-Refractory Paradoxical Inflammatory Reaction With Ruxolitinib. (2019) (2)
- Corrigendum: Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS) (2019) (2)
- The Youngbloods. Get Together. Hypercoagulation, Complement, and NET Formation in HIV/SIV Pathogenesis (2022) (2)
- Impact of innate immunity, endothelial damage, and metabolic biomarkers on COVID-19 severity and mortality (2022) (2)
- Cytomegalovirus immune reconstitution inflammatory syndrome manifesting as sialadenitis in an HIV-infected patient. (2013) (2)
- Complement activation by HIV-1-infected target cells enhances IL-2-stimulated but not unstimulated ADCC activity mediated by peripheral blood mononuclear cells. (1996) (2)
- The complement pathway is activated in people with HIV and is associated with non-AIDS comorbidities. (2021) (2)
- Association of low CD4/CD8 ratio with Adverse Cardiac Mechanics in Lymphopenic HIV-Infected Adults. (2020) (2)
- Factor X Inhibition Reduces Coagulation Activity But Not Inflammation Among Persons Living with HIV: A Randomized Clinical Trial (2019) (2)
- To Induce IRIS or Suppress It: The spectrum of Mycobacterium genavense in the antiretroviral era. (2020) (2)
- Towards a scalable HIV cure research agenda: the role of co-infections (2015) (2)
- Corrigendum to “D-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS” [Clin. Immunol. 136 (2010) 42–50] (2010) (2)
- ART in HIV-positive persons with low pre-treatment viremia: results from the START trial. (2019) (2)
- Depletion in the Colonic Mucosa of Patients With Idiopathic CD 4 + Lymphopenia (2015) (2)
- Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiation. (2021) (2)
- Trismus and voice change after starting tuberculosis treatment (2021) (1)
- Upbeat nystagmus in an HIV-positive patient with a tuberculoma in the medulla. (2018) (1)
- Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2 (2022) (1)
- Effects of Delays in Peripheral Blood Processing, Including Cryopreservation, on Detection of CD31 Expression on Naïve CD4 T Cells (2008) (1)
- Progressive multifocal leukoencephalopathy treated with interleukin-7 (2020) (1)
- Complement-driven inflammasome activation on circulating blood monocytes in immune reconstitution inflammatory syndrome in TB-HIV coinfected patients (2020) (1)
- Rapid Emergence of T Follicular Helper and Germinal Center B Cells Following Antiretroviral Therapy in Advanced HIV Disease (2021) (1)
- Feasibility and safety of research sigmoid colon biopsy in a cohort of Thai men who have sex with men with acute HIV-1 (2020) (1)
- Polyfunctional antigen specific CD4± T cell responses in Patients with HIV/AIDS and Histoplasmosis Immune Reconstitution Inflammatory Syndrome. (2022) (1)
- Prospective Clinical Trial of Mycophenolate Mofetil (MMF) De-Escalation in Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Immunodeficiency (PID): MMF Is Dispensable in Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide(PTCy)-Based HCT (2022) (1)
- The Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome (TB-IRIS) (2019) (1)
- Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected Patients. (2015) (1)
- Association between severe anaemia and inflammation, risk of IRIS and death in persons with HIV: A multinational cohort study (2022) (1)
- suggest a primary mechanism of receptor-mediated clearance Decreases in IL-7 levels during antiretroviral treatment of HIV infection (2013) (1)
- Relationship Between Anemia and Systemic Inflammation in People Living With HIV and Tuberculosis: A Sub-Analysis of the CADIRIS Clinical Trial (2022) (1)
- Frequency of CXCR3+ CD8+ T-Lymphocyte Subsets in Peripheral Blood Is Associated With the Risk of Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Development in Advanced HIV Disease (2022) (1)
- Antigen RecallT Cells That Preferentially Respond to + Distinguishes Small Resting Memory CD 4 Cutting Edge : L-Selectin ( CD 62 L ) Expression Lempicki (2002) (1)
- Changing lanes in ICL. (2010) (1)
- Acute tubular nephropathy in a patient with acute HIV infection: review of the literature (2014) (1)
- A 34-Year-Old Man With HIV/AIDS and a Cavitary Pulmonary Lesion. (2021) (1)
- Prevalence of Anti-lymphocyte Antibodies in Patients with Good Syndrome and Partial RAG Deficiency (2022) (1)
- Preserved Mucosal-Associated Invariant T-Cell Numbers and Function in Idiopathic CD4 Lymphocytopenia. (2021) (1)
- The effect of continuous versus pericycle antiretroviral therapy on IL-2 responsiveness. (2008) (1)
- Disseminated Mycobacterium marinum in HIV unmasked by Immune Reconstitution Inflammatory Syndrome. (2020) (1)
- CD4 T Cell Survival Following Intermittent IL-2 Therapy is Predictive of Increase in CD4 T Cell Count in HIV-Infected Patients (2009) (1)
- The Complement Pathway Is Activated in People With Human Immunodeficiency Virus and Is Associated With Non-AIDS Comorbidities (2021) (1)
- 232. Genomic Evidence for Dissemination of Mycobacterium marinum in an HIV Patient with Multifocal Cutaneous Disease (2019) (0)
- Successful Allogeneic Hematopoietic Cell Transplantation (HCT) with Low Toxicity and Gvhd in a Heterogeneous Cohort of Primary Immunodeficiency (PID) Patients (2019) (0)
- Editorial introductions. (2016) (0)
- Association of Low CD4/CD8 Ratio With Adverse Cardiac Mechanics in Lymphopenic HIV-Infected Adults. (2020) (0)
- Pilot trial of topical MTS‑01 application to reduce dermatitis in patients receiving chemoradiotherapy for stage I‑III carcinoma of the anal canal. (2022) (0)
- Postmortem MRI in Progressive Multifocal Leukoencephalopathy (P02.272) (2012) (0)
- Reply to Tham et al. (2016) (0)
- Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE) (2022) (0)
- Expanding role of biomarkers in characterising hyperinflammatory syndromes (2021) (0)
- 1381. M.genavense in the ART Era: From Persistent Disseminated Disease to Severe Disease (2019) (0)
- Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years. (2023) (0)
- Faculty Opinions recommendation of HIV-infected T cells are migratory vehicles for viral dissemination. (2012) (0)
- IL-15 acts as a potent inducer of CD4+CD25high cells expressing forkhead box protein P3 (95.6) (2007) (0)
- Reconstitution of immune responses occurs very rapidly after initiation of therapy for tuberculosis (43.54) (2007) (0)
- What’s Hot in HIV Basic Research (2016) (0)
- Administration of rhIL-7 Is Associated with Increase in Precursor T-Cells in Bone Marrows of Patients with Idiopathic CD4 Lymphocytopenia (2014) (0)
- 641Acute Retroviral Syndrome is Associated with Gut Mucosal CD4 Depletion, Inflammation and High Viral and Proviral Burden in Systemic and Tissue Compartments (2014) (0)
- Hallmarks of primate lentiviral immunodeficiency infection recapitulate loss of innate lymphoid cells (2018) (0)
- A pilot study of the effects of losartan vs. placebo on pneumoproteins in HIV: A secondary analysis of a randomized, double blind, study. (2021) (0)
- Prominent antibody mediated auto-immune response in idiopathic CD4 lymphopenic patients (2020) (0)
- Faculty Opinions recommendation of IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. (2011) (0)
- Faculty Opinions recommendation of Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation. (2013) (0)
- Differential expression of CXCR3 and CCR6 on CD4+ T-lymphocytes with distinct memory phenotypes characterizes tuberculosis-associated immune reconstitution inflammatory syndrome (2019) (0)
- 96. Human Papilloma Viruses Associated Diseases in a Cohort of Patients with Idiopathic CD4 Lymphopenia (2019) (0)
- Inflammatory Syndrome Associated Immune Reconstitution - Mycobacterium avium Role of IL-6 in (2013) (0)
- The Role of Inflammation and Immune Activation on Circulating Endothelial Progenitor Cells in Chronic HIV Infection (2021) (0)
- Humoral Reconstitution after Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients Pretreated with Targeted Anti-CD20 Therapy (2023) (0)
- PS1-32 Decreased IL-7 responsiveness of T lymphocytes in patients with idiopathic CD4 lymphopenia (2010) (0)
- PL4-2 Cytokine-based therapies in HIV infection: Lessons from IL-2 and expectations from IL-7 (2010) (0)
- Probe how race and gender intersect in author attribution (2022) (0)
- Sars-Cov-2 Infection and Vaccination in Recipients of Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide (PTCy)-Based Allogeneic Hematopoietic Cell Transplantation (HCT) (2022) (0)
- Immunometabolism and HIV-1 pathogenesis: food for thought (2020) (0)
- IL-7 Immunotherapy in Idiopathic CD4 Lymphopenia (2015) (0)
- No effect of HBsAg positivity on antibody response after COVID-19 vaccine (2022) (0)
- Cells That Preferentially Respond to Recall T Distinguishes Small Resting Memory CD4+ Cutting Edge: L-Selectin (CD62L) Expression (2013) (0)
- Improvement of liver metabolic activity in people with advanced HIV after antiretroviral therapy initiation (2022) (0)
- Corrigendum to: Impact of Acute HIV Infection and Early Antiretroviral Therapy on the Human Gut Microbiome. (2020) (0)
- Phase I/II study of the safety, pharmacokinetics, and efficacy of pomalidomide in the treatment of Kaposi sarcoma in individuals with or without HIV. (2013) (0)
- High prevalence of gastrointestinal manifestations among Cytomegalovirus end-organ disease in the combination antiretroviral era (2021) (0)
- Mycobacterial Immune Reconstitution Inflammatory Syndrome in HIV is Associated With Protein-Altering Variants in Hemophagocytic Lymphohistiocytosis-Related Genes. (2023) (0)
- Author Correction: Differential expression of CXCR3 and CCR6 on CD4+ T-lymphocytes with distinct memory phenotypes characterizes tuberculosis-associated immune reconstitution inflammatory syndrome (2019) (0)
- Evidence of T cell lymphopenia in the colonic mucosa in idiopathic CD4 lymphocytopenia patients (HEM4P.250) (2014) (0)
- Clinical Considerations During Breakthrough Coronavirus Disease 2019 Infections in Vaccinated Individuals With Autoimmunity (2021) (0)
- Mycobacterium Avium Complex (MAC)-Associated Immune Reconstitution Inflammatory Syndrome (IRIS) Following Allogeneic Bone Marrow Transplantation (alloBMT) (2018) (0)
- HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases (2020) (0)
- Distinct Disease Profiles in Tuberculosis Metalloproteinase-1 Expression Underlies Heme Oxygenase-1 Regulation of Matrix (2015) (0)
- Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV (2023) (0)
- Cardiovascular Biomarker Profile on Antiretroviral Therapy Is Not Influenced by History of an IRIS Event in People With HIV and Suppressed Viremia. (2020) (0)
- CCR2 identifies first responders among human CD4+ memory T cells: long-lived, apoptosis-resistant, antigen-responsive cells with enhanced migration potential, a low threshold for activation, and immediate effector capabilities (85.5) (2007) (0)
- Persistence of HIV-associated Cerebral Toxoplasmosis Lesions in Successfully Treated Patients Receiving Combination Anti-retroviral Therapy (2023) (0)
- Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection (2018) (0)
- after endotoxin challenge in humans Gene expression profiles of peripheral blood leukocytes (2011) (0)
- Choroid Plexitis and Ependymitis by Magnetic Resonance Imaging are Biomarkers of Neuronal Damage and Inflammation in HIV-negative Cryptococcal Meningoencephalitis (2017) (0)
- HIV Populations Shift After Tuberculosis Associated Immune Reconstitution Inflammatory Syndrome: Implications For HIV Remission (2020) (0)
- Use of humanized mouse models for the study of idiopathic CD4 lymphocytopenia (HUM7P.313) (2014) (0)
This paper list is powered by the following services:
Other Resources About Irini Sereti
What Schools Are Affiliated With Irini Sereti?
Irini Sereti is affiliated with the following schools:
